Status:
COMPLETED
Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes
Lead Sponsor:
University Hospital Dubrava
Conditions:
Diabetes Mellitus, Type 2
Education
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Type 2 diabetes mellitus (T2DM) is a chronic progressive disease that affects more than 400 million people worldwide. There are a few studies evaluating ADRs in diabetics. Many patients experience ADR...
Detailed Description
Type 2 diabetes mellitus (T2DM) is a chronic progressive disease that affects more than 400 million people worldwide. Besides adapting their lifestyle, a large majority of diabetic patients needs phar...
Eligibility Criteria
Inclusion
- age 18 years or older,
- diagnosis of T2DM and
- hospital discharge to the community.
Exclusion
- cognitive disorders that would interfere with patient's participation,
- diagnosis of a terminal illness with a life expectancy \<1 month,
- discharge to a long-term care facility or
- inability to be followed-up.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03438162
Start Date
April 1 2018
End Date
July 1 2018
Last Update
November 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Dubrava
Zagreb, Croatia, 10000